Status:
COMPLETED
Regulatory T-cells After Subcutaneous Immunotherapy
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Grass Pollen Allergy
Specific Immunotherapy
Eligibility:
All Genders
7-28 years
Brief Summary
The primary endpoint was the induction of T-regulatory cells under s specific subcutaneous immunotherapy (SCIT). Patients suffering from grass pollen allergy (relevant clinical symptomes during the po...
Eligibility Criteria
Inclusion
- informed consent,
- clinically relevant grass pollen allergy,
- age \> 6 and \< 28
Exclusion
- severe unstable asthma,
- regular ingestion of antihistamine,
- systemic steroid therapy,
- lung funtcion VC \< 70%,
- FEV1 \< 65%
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT01830673
Start Date
October 1 2011
End Date
October 1 2012
Last Update
July 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johann Wolfgang Goethe-university
Frankfurt/M, Hesse, Germany, 60590